Investor Relations

TFF Pharmaceuticals, Inc. is an early-stage biopharmaceutical company focused on the development and commercialization of new inhalation products for the treatment of chronic respiratory diseases and lung conditions.

In early testing the Thin Film Freezing (TFF) proprietary platform significantly improved the solubility of drugs that have poor water solubility.

Jan 11, 2021 6:00 AM EST: TFF Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference


TFF Pharmaceuticals Corporate Overview – March 2020


Data Provided by Refinitiv. Minimum 15 minutes delayed.

Press Releases